GDF15 and myeloid sarcoma: Serum GDF15 has been linked in recent research to the development of cancer and cardiovascular disease; however, there are still fewer studies examining the connection between serum GDF15 and T2DM in combination with MS, and the clinical application has not yet been promoted.